哮喘中的气道平滑肌：仅仅是支气管扩张的靶点吗？
Airway smooth muscle in asthma: just a target for bronchodilation?
机构信息
University of Sydney, Discipline of Pharmacology and Woolcock Institute of Medical Research, University of Sydney, Sydney, New South Wales, 2006, Australia.
出版信息
Clin Chest Med. 2012 Sep;33(3):543-58. doi: 10.1016/j.ccm.2012.05.002. Epub 2012 Jul 11.
Abstract
Airway smooth muscle (ASM) has long been recognized as the main cell type responsible for bronchial hyperresponsiveness. It has, thus, been considered as a target for bronchodilation. In asthma, however, there is a complex relationship between ASM and inflammatory cells, such as mast cells and T lymphocytes. Moreover, the increased ASM mass in asthmatic airways is one of the key features of airway remodeling. This article aims to review the main concepts about the 3 possible roles of ASM in asthma: (1) contractile tone, (2) inflammatory response, and (3) remodeling.
摘要
气道平滑肌（ASM）一直被认为是导致支气管高反应性的主要细胞类型。因此，ASM 一直被视为支气管扩张的靶点。然而，在哮喘中，ASM 与炎症细胞（如肥大细胞和 T 淋巴细胞）之间存在复杂的关系。此外，哮喘气道中 ASM 质量的增加是气道重塑的关键特征之一。本文旨在综述 ASM 在哮喘中可能发挥的 3 种作用的主要概念：（1）收缩张力，（2）炎症反应，和（3）重塑。
相似文献
1
Airway smooth muscle in asthma: just a target for bronchodilation?哮喘中的气道平滑肌：仅仅是支气管扩张的靶点吗？
Clin Chest Med. 2012 Sep;33(3):543-58. doi: 10.1016/j.ccm.2012.05.002. Epub 2012 Jul 11.
2
Regulation of Airway Smooth Muscle Contraction in Health and Disease.气道平滑肌收缩的调节：在健康和疾病中的作用。
Adv Exp Med Biol. 2019;1124:381-422. doi: 10.1007/978-981-13-5895-1_16.
3
Airway smooth muscle in asthma: linking contraction and mechanotransduction to disease pathogenesis and remodelling.哮喘中的气道平滑肌：将收缩和机械转导与疾病发病机制及重塑相联系
Pulm Pharmacol Ther. 2014 Dec;29(2):96-107. doi: 10.1016/j.pupt.2014.07.005. Epub 2014 Jul 23.
4
Roles of cysteinyl leukotrienes in airway inflammation, smooth muscle function, and remodeling.半胱氨酰白三烯在气道炎症、平滑肌功能及重塑中的作用。
J Allergy Clin Immunol. 2003 Jan;111(1 Suppl):S18-34; discussion S34-6. doi: 10.1067/mai.2003.25.
5
Airway remodeling and airway smooth muscle in asthma.哮喘中的气道重塑与气道平滑肌
Allergol Int. 2006 Sep;55(3):235-43. doi: 10.2332/allergolint.55.235.
6
Airway smooth muscle pathophysiology in asthma.哮喘中的气道平滑肌病理生理学。
J Allergy Clin Immunol. 2021 Jun;147(6):1983-1995. doi: 10.1016/j.jaci.2021.03.035.
7
Do inflammatory mediators influence the contribution of airway smooth muscle contraction to airway hyperresponsiveness in asthma?炎症介质是否影响气道平滑肌收缩对哮喘气道高反应性的作用？
J Appl Physiol (1985). 2003 Aug;95(2):844-53. doi: 10.1152/japplphysiol.00192.2003.
8
Airway remodeling in asthma: update on mechanisms and therapeutic approaches.哮喘中的气道重塑：机制和治疗方法的最新进展。
Curr Opin Pulm Med. 2018 Jan;24(1):56-62. doi: 10.1097/MCP.0000000000000441.
9
Does the length dependency of airway smooth muscle force contribute to airway hyperresponsiveness?气道平滑肌力量的长度依赖性是否导致气道高反应性？
J Appl Physiol (1985). 2013 Nov 1;115(9):1304-15. doi: 10.1152/japplphysiol.01480.2012. Epub 2013 Aug 22.
10
Airway structural components drive airway smooth muscle remodeling in asthma.气道结构成分在哮喘中驱动气道平滑肌重塑。
Proc Am Thorac Soc. 2009 Dec;6(8):683-92. doi: 10.1513/pats.200907-056DP.
引用本文的文献
1
Methacholine hyperresponsiveness in mice with house dust mite-induced lung inflammation is not associated with excessive airway constriction ex vivo.在屋尘螨诱导的肺部炎症小鼠中，乙酰甲胆碱高反应性与体外气道过度收缩无关。
Exp Physiol. 2025 Sep;110(9):1336-1348. doi: 10.1113/EP092522. Epub 2025 Mar 28.
2
Bronchial thermoplasty for severe asthma: potential mechanisms and response markers.支气管热成形术治疗严重哮喘：潜在机制和反应标志物。
Ther Adv Respir Dis. 2024 Jan-Dec;18:17534666241266348. doi: 10.1177/17534666241266348.
3
Inhibition of γ-glutamyl transferase suppresses airway hyperresponsiveness and airway inflammation in a mouse model of steroid resistant asthma exacerbation.γ-谷氨酰转移酶抑制可抑制类固醇耐药性哮喘加重小鼠模型的气道高反应性和气道炎症。
Front Immunol. 2023 Jun 12;14:1132939. doi: 10.3389/fimmu.2023.1132939. eCollection 2023.
4
Targeting of G-protein coupled receptor 40 alleviates airway hyperresponsiveness through RhoA/ROCK1 signaling pathway in obese asthmatic mice.靶向 G 蛋白偶联受体 40 通过 RhoA/ROCK1 信号通路减轻肥胖型哮喘小鼠的气道高反应性。
Respir Res. 2023 Feb 17;24(1):56. doi: 10.1186/s12931-023-02361-1.
5
Paucigranulocytic Asthma: Potential Pathogenetic Mechanisms, Clinical Features and Therapeutic Management.少粒细胞性哮喘：潜在的发病机制、临床特征及治疗管理
J Pers Med. 2022 May 23;12(5):850. doi: 10.3390/jpm12050850.
6
Recent advances in bronchial thermoplasty for severe asthma: a narrative review.重度哮喘支气管热成形术的最新进展：一项叙述性综述。
Ann Transl Med. 2022 Mar;10(6):370. doi: 10.21037/atm-22-580.
7
Metabolomics in asthma: A platform for discovery.哮喘中的代谢组学：发现的平台。
Mol Aspects Med. 2022 Jun;85:100990. doi: 10.1016/j.mam.2021.100990. Epub 2021 Jul 17.
8
Nicotinic α7 acetylcholine receptor (α7nAChR) in human airway smooth muscle.人呼吸道平滑肌中的烟碱型乙酰胆碱受体α7 亚型（α7nAChR）。
Arch Biochem Biophys. 2021 Jul 30;706:108897. doi: 10.1016/j.abb.2021.108897. Epub 2021 May 15.
9
EVs from BALF-Mediators of Inflammation and Potential Biomarkers in Lung Diseases.肺泡灌洗液来源的细胞外囊泡：炎症介质和肺部疾病的潜在生物标志物。
Int J Mol Sci. 2021 Apr 1;22(7):3651. doi: 10.3390/ijms22073651.
10
Extracellular Vesicles from Airway Secretions: New Insights in Lung Diseases.气道分泌物中的细胞外囊泡：肺部疾病的新见解。
Int J Mol Sci. 2021 Jan 8;22(2):583. doi: 10.3390/ijms22020583.
本文引用的文献
1
What effect does asthma treatment have on airway remodeling? Current perspectives.哮喘治疗对气道重塑有什么影响？ 当前的观点。
J Allergy Clin Immunol. 2011 Sep;128(3):439-48; quiz 449-50. doi: 10.1016/j.jaci.2011.06.002. Epub 2011 Jul 12.
2
p38 mitogen-activated protein kinase pathways in asthma and COPD.p38 丝裂原活化蛋白激酶通路在哮喘和 COPD 中的作用。
Chest. 2011 Jun;139(6):1470-1479. doi: 10.1378/chest.10-1914.
3
Effect of bronchoconstriction on airway remodeling in asthma.支气管收缩对哮喘气道重塑的影响。
N Engl J Med. 2011 May 26;364(21):2006-15. doi: 10.1056/NEJMoa1014350.
4
Human lung mast cells modulate the functions of airway smooth muscle cells in asthma.人肺肥大细胞调节哮喘患者气道平滑肌细胞的功能。
Allergy. 2011 Sep;66(9):1231-41. doi: 10.1111/j.1398-9995.2011.02616.x. Epub 2011 May 10.
5
Interleukin-13 inhibits proliferation and enhances contractility of human airway smooth muscle cells without change in contractile phenotype.白细胞介素-13 抑制人呼吸道平滑肌细胞的增殖并增强其收缩性，而不改变收缩表型。
Am J Physiol Lung Cell Mol Physiol. 2011 Jun;300(6):L958-66. doi: 10.1152/ajplung.00247.2010. Epub 2011 Apr 1.
6
The role of mast cells in the structural alterations of the airways as a potential mechanism in the pathogenesis of severe asthma.肥大细胞在气道结构改变中的作用及其在重度哮喘发病机制中的潜在机制。
Curr Pharm Des. 2011;17(7):685-98. doi: 10.2174/138161211795428975.
7
Pathophysiology of bronchial smooth muscle remodelling in asthma.哮喘支气管平滑肌重塑的病理生理学。
Eur Respir J. 2010 Nov;36(5):1174-84. doi: 10.1183/09031936.00019810.
8
Fibulin-1 is increased in asthma--a novel mediator of airway remodeling?纤维连接蛋白-1 在哮喘中增加——气道重塑的新型介质？
PLoS One. 2010 Oct 13;5(10):e13360. doi: 10.1371/journal.pone.0013360.
9
Mast cell fibroblastoid differentiation mediated by airway smooth muscle in asthma.哮喘中气道平滑肌介导的肥大细胞成纤维样细胞分化。
J Immunol. 2010 Nov 15;185(10):6105-14. doi: 10.4049/jimmunol.1000638. Epub 2010 Oct 15.
10
Anti-mitogenic effects of β-agonists and PGE2 on airway smooth muscle are PKA dependent.β-激动剂和 PGE2 对气道平滑肌的抗有丝分裂作用依赖于 PKA。
FASEB J. 2011 Jan;25(1):389-97. doi: 10.1096/fj.10-164798. Epub 2010 Aug 30.
Zotero 插件